In the intricate symphony of human physiology, few instruments play a more pivotal role than the heart. A marvel of ...

此次FDA批准注册标志着公司产品获得进入美国市场销售的资质，这将对产品在海外市场的推广和销售产生积极影响。然而，公告中也提到，产品在相应市场的实际销售情况将受到未来市场推广效果、海外市场政策环境变化以及汇率波动等因素的影响，目前尚无法预测对公司未来经 ...

Coinciding with the FDA’s clearance for the catheter, Perfuze has also completed a €22m ($24m) financing round.

天眼查资料显示，维力医疗成立于2004年04月30日，注册资本29286.8018万人民币，法定代表人韩广源，注册地址为广州市番禺区化龙镇金湖工业城C区4号。主营业务为麻醉、导尿、泌尿外科、护理、呼吸、 血液透析 ...

在国际医疗市场中，FDA的认可无疑是一种权威背书。这意味着，该产品不仅在质量、安全性上符合严格标准，还具备进入北美市场的资质。获得FDA批准的产品能更容易地被医生推荐，患者使用，从而推动企业的销售增长。这样的认可，为维力医疗的国际化之路铺平了道路。

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8523 ...

Basis Medical recently announced that its Seclusion catheter for the treatment of superficial vein reflux has received FDA ...

Olubadewa A. Fatunde and Win-Kuang Shen. Catheter Ablation as the First-Line Therapy for Atrial Fibrillation: Update on Evidence and Clinical Implications. CVIA. 2025. Vol. 10 (1). DOI: ...

VTAK股价已跌至52周新低0.31美元，较52周高点8.40美元下跌96%，公司正在应对充满挑战的市场环境。根据 InvestingPro 分析，尽管目前面临挑战，该公司仍保持着90.5%的高毛利率。这一显著下跌反映了RA Medical ...

Perfuze, a medtech has raised €22m. With the infusion, the company will release its catheters to select stroke centres in the US.

Stereotaxis STXS recently submitted an application seeking FDA regulatory clearance for its EMAGIN 5F catheter, marking a ...